Fulcrum Therapeutics
-$1.29 (-9.19%) As of 3:04 PM UTC today
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell FULC and other ETFs, options, and stocks.
About FULC
Fulcrum Therapeutics, Inc. is a clinical stage biopharmaceutical company. The firm develops new medicines and focuses on unlocking gene control mechanisms to develop small molecule therapies.
CEO
Bryan E Stuart
Employees
73
Headquarters
Cambridge, Massachusetts
Founded
2015
FULC Key Statistics
Market cap
500.79M
Price-Earnings ratio
—
Dividend yield
—
Average volume
718.16K
High today
$14.36
Low today
$12.19
Open price
$14.11
Volume
205.39K
52 Week high
$33.10
52 Week low
$6.85
Analyst ratings
86%
of 7 ratings
Buy
85.7%
Hold
0%
Sell
14.3%
FULC Earnings
-$0.81
-$0.54
-$0.27
$0.00
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Estimated
— per share
Actual
Expected Mar 3, Pre-Market